Gentherm Incorporated (THRM)
| Market Cap | 1.19B +9.1% |
| Revenue (ttm) | 1.58B +8.7% |
| Net Income | 26.57M -16.0% |
| EPS | 0.86 -15.6% |
| Shares Out | 30.71M |
| PE Ratio | 45.22 |
| Forward PE | 13.25 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 17,069 |
| Open | 38.77 |
| Previous Close | 38.33 |
| Day's Range | 38.41 - 38.90 |
| 52-Week Range | 27.00 - 48.35 |
| Beta | 1.34 |
| Analysts | Buy |
| Price Target | 47.71 (+23.0%) |
| Earnings Date | Oct 22, 2026 |
About THRM
Gentherm Incorporated designs, develops, manufactures, and sells thermal management and pneumatic comfort technologies in the United States, China, Germany, Czech Republic, South Korea, Mexico, Slovakia, Romania, Japan, United Kingdom and internationally. It operates in two segments, Automotive and Medical. The company offers climate comfort systems, including seat heaters, blowers, and thermoelectric devices for variable temperature climate control seats and steering wheel heaters to provide thermal comfort to automobile passengers; integrated... [Read more]
Financial Performance
In 2025, Gentherm's revenue was $1.50 billion, an increase of 2.92% compared to the previous year's $1.46 billion. Earnings were $18.29 million, a decrease of -71.85%.
Financial StatementsAnalyst Summary
According to 8 analysts, the average rating for THRM stock is "Buy." The 12-month stock price target is $47.71, which is an increase of 23.00% from the latest price.
News
Gentherm shareholders approve combination with Modine’s Performance Technologies
Gentherm (THRM) announced that, at the Company’s Special Meeting of Shareholders held, Gentherm shareholders voted to approve the proposals required to complete the proposed combination of Modine’s Pe...
Gentherm Shareholders Approve Combination with Modine's Performance Technologies Business
NOVI, Mich., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ:THRM), (the “Company” or “Gentherm”), a global market leader of innovative thermal management and pneumatic comfort technologies, today...
Gentherm Transcript: AGM 2026
Shareholders approved the issuance of shares and an amendment to increase authorized shares for a merger. The adjournment proposal was not needed as the first two proposals passed. Final vote tallies will be disclosed in an SEC filing.
Gentherm management to meet with Seaport Research
Meeting to be held in Northville, MI on August 26 hosted by Seaport Research.
Gentherm Transcript: J.P. Morgan Automotive Conference
A major acquisition with Modine will diversify the business, reduce light vehicle exposure, and unlock $100 million in cross-selling synergies by 2030. Operational improvements and strong growth in automotive, home, office, and medical markets support a path to $3.5 billion revenue and 15%+ EBITDA margins by decade’s end.
Gentherm Slides: J.P. Morgan Automotive Conference
Gentherm has posted slides in relation to its latest quarterly earnings report, which was published on August 13, 2026.
Gentherm Announces Participation in J.P. Morgan Auto Conference and Seaport Annual Summer Investor Conference
Gentherm announces participation in the J.P. Morgan Auto Conference on August 13, 2026, and the Seaport Summer Investor Conference on August 18, 2026.
Gentherm price target raised to $50 from $39 at Roth Capital
Roth Capital analyst Matt Koranda raised the firm’s price target on Gentherm (THRM) to $50 from $39 and keeps a Buy rating on the shares. Gentherm delivered record quarterly product…
Gentherm downgraded to Hold from Buy at Freedom Broker
Freedom Broker analyst Alinur Beisenbay downgraded Gentherm (THRM) to Hold from Buy with a price target of $40, up from $37. The firm cites valuation for the downgrade following the…
Gentherm price target raised to $48 from $41 at JPMorgan
JPMorgan analyst Rajat Gupta raised the firm’s price target on Gentherm (THRM) to $48 from $41 and keeps a Neutral rating on the shares.
Gentherm price target raised to $59 from $44 at Stifel
Stifel raised the firm’s price target on Gentherm (THRM) to $59 from $44 and keeps a Buy rating on the shares after the company released “strong” Q2 results. Published first…
Gentherm Earnings Call Transcript: Q2 2026
Strong Q2 results with 11% revenue growth and record product revenue, driven by broad-based automotive outperformance and expansion into home, office, and medical markets. Raised 2026 guidance, completed IME acquisition, and advanced the Modine merger, positioning for diversified growth and robust cash flow.
Gentherm Earnings release: Q2 2026
Gentherm released its Q2 2026 earnings on July 23, 2026, summarizing the period's financial results.
Gentherm Slides: Q2 2026
Gentherm has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 23, 2026.
Gentherm Quarterly report: Q2 2026
Gentherm has published its Q2 2026 quarterly earnings report on July 23, 2026.
Gentherm reports Q2 adjusted EPS 75c, consensus 56c
Reports Q2 revenue $416.2M, consensus $382.87M. “The Gentherm (THRM) team demonstrated strong commercial performance with record quarterly revenue, while also scaling our core technologies into new ma...
Gentherm raises FY26 product revenue view to $1.55B-$1.65B from $1.5B-$1.6B
FY26 revenue consensus $1.56B. Raises FY26 adjusted EBITDA view to $185M-$200M from $175M-$195M; Adjusted free cash flow view to $85M-$100M from $80M-$100M.
Gentherm authorizes new $400M stock repurchase program
The Board of Directors authorized a new stock repurchase program of up to $400M of the company’s issued and outstanding common stock. The new program will replace the company’s existing…
Gentherm Reports 2026 Second Quarter Results and Announces a New Increased Stock Repurchase Authorization
Revenue Growth of 9.5% (ex-FX) Year-over-Year Delivered Record Quarterly Revenue of $416 Million 2026 Full Year Guidance Raised Board Authorized New Stock Repurchase Program of up to $400 Million Stra...
Gentherm acquires Innovative Medical Equipment, terms undisclosed
Gentherm (THRM) announced it has acquired Innovative Medical Equipment. “We are intent on transforming Gentherm by building on our leadership in thermal management and expanding into markets where our...
Gentherm Acquires Innovative Medical Equipment, LLC, Strengthening Medical Product Portfolio and Customer Channels
Gentherm acquires Innovative Medical Equipment, adding ThermaZone thermal therapy technology to expand its medical portfolio and growth opportunities.
Gentherm receives FDA clearance for ThermAffyx Patient Safety System
Gentherm (THRM) announced it received FDA 510 clearance for its patented ThermAffyx Patient Safety System. This Class II medical device combines active patient warming, securement and pressure reducti...
Gentherm Medical Receives FDA Clearance for ThermAffyx™ Patient Safety System
NOVI, Mich., July 20, 2026 (GLOBE NEWSWIRE) -- Gentherm, a global market leader of innovative thermal management and pneumatic comfort technologies, announced today it received FDA 510(k) clearance fo...
Gentherm price target raised to $44 from $38 at Stifel
Stifel raised the firm’s price target on Gentherm (THRM) to $44 from $38 and keeps a Buy rating on the shares. In a Q2 preview for the firm’s diversified industrials…
Gentherm price target raised to $41 from $38 at JPMorgan
JPMorgan raised the firm’s price target on Gentherm (THRM) to $41 from $38 and keeps a Neutral rating on the shares. The firm sees the average auto supplier to come…